Načítá se...
Characterizing Glioblastoma Heterogeneity via Single-Cell Receptor Quantification
Dysregulation of tyrosine kinase receptor (RTK) signaling pathways play important roles in glioblastoma (GBM). However, therapies targeting these signaling pathways have not been successful, partially because of drug resistance. Increasing evidence suggests that tumor heterogeneity, more specificall...
Uloženo v:
| Vydáno v: | Front Bioeng Biotechnol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6050407/ https://ncbi.nlm.nih.gov/pubmed/30050899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2018.00092 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|